E
G. Bassolino et al.
Paper
Synthesis
TruSpec Micro instrument. Melting points were measured on a Büchi
Melting Point M-560 instrument and are uncorrected; unless other-
vealed the presence of a dibrominated byproduct (m/z = 374). The
mixture was treated with HCl (0.1 M) and extracted three times with
CH2Cl2. The combined organic phases were dried over MgSO4 and the
solvent was removed under reduced pressure. The product was fixed
on Celite and purified by silica gel column chromatography (CH2Cl2–
EtOAc, 99.5:0.5) to yield an orange solid; yield: 490 mg (70%).
wise given, the temperature gradient used was 20 °C·min–1
.
7-(Azetidin-1-yl)-4-(hydroxymethyl)-2H-chromen-2-one (3)
Compound 11 (400 mg, 1.86 mmol) was added to a flame-dried
multi-neck flask and suspended in anhydrous THF (34 mL). The sus-
pension was stirred for 10 min at r.t., then cooled to –40 °C in an ace-
tone–dry ice bath, and LiHMDS (1 M in THF; 4.7 mL, 4.7 mmol) was
added dropwise to the mixture through a dropping funnel. The solu-
tion was warmed to –30 °C, followed by cooling to –78 °C. A freshly
prepared solution of N-bromosuccinimide (364 mg, 2.05 mmol) in
anhydrous THF (6 mL) was added dropwise through a dropping fun-
nel, ensuring that the temperature did not rise above –70 °C. The
solution was kept stirring at –78 °C for about 1 h, when LC/MS and
TLC analyses revealed the presence of a dibrominated byproduct
(m/z = 374). The reaction was quenched with HCl (0.1 M) and the
mixture repeatedly extracted with CH2Cl2. The combined organic
phases were dried over MgSO4, and the solvent was removed under
reduced pressure until an orange solid was obtained. KF (118 mg, 2.04
mmol) was flame-dried in a separate two-neck flask. The crude of the
bromination reaction was added as a solid, and the system was evacu-
ated and backfilled with nitrogen three times. The solids were sus-
pended in anhydrous DMF (10 mL) and TFA–H2O (4:1, 450 μL) was
added to the flask (2.5 equiv of each). The flask was sealed, and the
system was stirred at 40 °C for 12–15 h, until completion, as indicated
by TLC (silica gel; CH2Cl2–EtOAc, 95:5) by the disappearance of the in-
termediate bromide 4. CH2Cl2 was added and the organic phase was
washed with H2O. The aqueous phase was back-extracted once with
CH2Cl2. The combined organic phases were washed with brine, dried
over MgSO4, and concentrated under reduced pressure until a solid
was obtained. The crude was dissolved in CH2Cl2 and as little MeOH as
possible, and was fixed on Celite. The product was purified by silica
gel column chromatography (CH2Cl2–Et2O, 95:5 → 8:2), and isolated
as a yellow-orange powder; yield: 290 mg (67%).
Mp 200 °C (when measured with a slower gradient of 5 °C·min–1, a
color change was observed around 185 °C, yielding a solid that does
not melt at 200 °C); Rf = 0.55 (silica gel; CH2Cl2–EtOAc, 95:5).
IR (neat): 1723, 1617, 1529, 1412, 1306, 1230, 1161 cm–1
.
1H NMR (400 MHz, CDCl3): δ = 7.48 (d, J = 8.7 Hz, 1 H, H-3), 6.33 (dd,
J = 8.7, 2.3 Hz, 1 H, H-2), 6.22 (d, J = 2.3 Hz, 1 H, H-1), 6.17 (s, 1 H, H-
4), 4.40 (s, 2 H, H-5), 4.01 (t, J = 7.3 Hz, 4 H, H-6), 2.45 (quint, J = 7.4
Hz, 2 H, H-7).
13C NMR (100 MHz, CDCl3): δ = 161.6, 156.4, 154.2, 150.6, 125.4,
110.1, 108.0, 107.4, 97.3, 51.8, 27.3, 16.6.
HRMS-ESI: m/z [M + H]+ calcd for C13H13NO2Br: 294.0124; found:
294.0118.
Anal. Calcd for C13H12NO2Br: C, 53.08; H, 4.11; N, 4.76. Found:
C, 53.02; H, 4.18; N, 4.62.
7-(Azetidin-1-yl)-4-methyl-2H-chromen-2-one (11)17
4-Methyl-2-oxo-2H-chromen-7-yl trifluoromethanesulfonate (800
mg, 2.6 mmol), RuPhos (182 mg, 0.4 mmol), RuPhos Pd G3 (334 mg,
0.4 mmol), and Cs2CO3 (1.27 g, 3.9 mmol) were transferred to a flame-
dried Schlenk flask, which was evacuated and backfilled with nitro-
gen three times. Anhydrous toluene (21 mL) was added, followed by
azetidine (0.2 mL, 162 mg, 2.8 mmol). The reaction mixture was
stirred for 15 h at 80 °C, then filtered over Celite, fixed on Celite, puri-
fied by silica gel column chromatography (CH2Cl2–EtOAc, 99:1), and
washed with pentane to yield compound 11 as a bright yellow solid;
yield: 360 mg (65%).
Rf = 0.42 (silica gel; CH2Cl2–EtOAc, 95:5).
1H NMR (400 MHz, CDCl3): δ = 7.38 (d, J = 8.6 Hz, 1 H, H-3), 6.30 (dd,
J = 8.6, 2.3 Hz, 1 H, H-2), 6.21 (d, J = 2.3 Hz, 1 H, H-1), 5.97 (q, J = 1.2
Hz, 1 H, H-4), 3.99 (t, J = 7.3 Hz, 4 H, H-6), 2.43 (quint, J = 7.3 Hz, 2 H,
H-7), 2.34 (d, J = 1.2 Hz, 3 H, H-5).
13C NMR (100 MHz, CDCl3): δ = 162.1, 155.7, 154.1, 153.1, 125.5,
110.4, 109.6, 107.8, 97.2, 51.9, 18.7, 16.6.
Mp 198 °C; Rf = 0.25 (silica gel; CH2Cl2–Et2O, 7:3).
IR (neat): 3386, 1690, 1600, 1530, 1415, 1090 cm–1
1H NMR (400 MHz, DMSO-d6): δ = 7.45 (d, J = 8.7 Hz, 1 H, H-3), 6.36
(dd, J = 8.7, 2.3 Hz, 1 H, H-2), 6.26 (d, J = 2.3 Hz, 1 H, H-1), 6.11 (t,
J = 1.5 Hz, 1 H, H-4), 5.51 (t, J = 5.6 Hz, 1 H, H-8), 4.67 (dd, J = 5.6, 1.5
Hz, 2 H, H-5), 3.93 (t, J = 7.4 Hz, 4 H, H-6), 2.35 (quint, J = 7.4 Hz, 2 H,
H-7).
.
HRMS-ESI: m/z [M + H]+ calcd for C13H14NO2: 216.1019; found:
13C NMR (100 MHz, DMSO-d6): δ = 160.9, 157.0, 155.1, 153.7, 124.9,
216.1019.
107.8, 106.9, 104.6, 96.3, 59.1, 51.5, 15.9.
(7-(Azetidin-1-yl)-2-oxo-2H-chromen-4-yl)methyl Diethyl Phos-
phate (16)
HRMS-ESI: m/z [M + H]+ calcd for C13H14NO3: 232.0968; found:
232.0970.
Compound 3 (50 mg, 0.21 mmol) and DMAP (3 mg, 0.02 mmol) were
added to a flame-dried flask, and the system was evacuated and back-
filled with nitrogen three times. Anhydrous THF (1 mL) and Et3N (46
μL, 0.33 mmol) were added. A solution of diethyl chlorophosphate (35
μL, 0.24 mmol) in THF (1 mL) was added dropwise. The reaction mix-
ture was stirred at r.t. for 12–15 h, until the starting material was con-
sumed, as determined by TLC (silica gel; CH2Cl2–Et2O, 7:3). Upon
completion, CH2Cl2 was added, and the organic phase was washed
with H2O. The aqueous phase was back-extracted once with CH2Cl2.
The combined organic phases were washed with brine, dried over
MgSO4, and concentrated under reduced pressure. The crude was dis-
solved in CH2Cl2 and fixed on Celite. The product was purified by sili-
ca gel column chromatography (CH2Cl2–Et2O, 92:8 → 95:5), followed
by HPLC [solvent A: H2O, solvent B: MeCN; flow: 1 mL·min–1; 0–1
min: 50% A; 1–6.5 min: 50–20% A; 6.5–7.5 min: 20–10% A; 7.5–9 min:
Anal. Calcd for C13H13NO3·0.33 H2O: C, 65.81; H, 5.81; N, 5.90. Found:
C, 65.50; H, 5.68; N, 5.85.
7-(Azetidin-1-yl)-4-(bromomethyl)-2H-chromen-2-one (4)
Compound 11 (500 mg, 2.32 mmol) was added to a flame-dried
multi-neck flask and suspended in anhydrous THF (45 mL). The sus-
pension was cooled to –40 °C in an acetone–dry ice bath, and LiHMDS
(1 M in THF; 5.81 mL, 5.81 mmol) was added dropwise to the mixture
through a dropping funnel. The dropping funnel was rinsed by adding
THF (1 mL). The solution was warmed to –30 °C, followed by cooling
to –78 °C. A solution of N-bromosuccinimide (455 mg, 2.55 mmol) in
anhydrous THF (7 mL) was freshly prepared in a flame-dried flask and
added dropwise, and the mixture was stirred at –78 °C. The reaction
mixture was neutralized after 1 h, when LC/MS and TLC analyses re-
© Georg Thieme Verlag Stuttgart · New York — Synthesis 2017, 49, A–G